Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rozenblit who wrote (3255)	11/1/1999 12:54:00 PM
From: rl	Respond to of 3369

Don't know if your idea would fly. But do know there won't be much left. When the lawsuits finally hit, SALV will have had to sell 100 million tests to pay off. The bankruptcy will have creditors lining up. Unfortunately, people like McLaughlin will be there for even more of a handout. I can't even imagine what good news RSH is talking about. SALV is way beyond any hope of an acquisition or turn around. Far too much debt for any chance of redemption. Even if gigntic sales are forthcoming. By the way. Who is selling now that Slowey has gone to work for a rival, Epitope? But that won't stop the piggies from attempting more pump and dumps.